Source: Health Canada shortage reports · Updated Jul 29, 2026
Granisetron is in a widespread shortage in Canada. 2 of 2 reported products are affected. The latest manufacturer estimate for full recovery is Aug 10, 2026.
An anti-nausea medication used to prevent nausea and vomiting caused by chemotherapy or surgery.
Products affected
2 / 2
In shortage since
Jan 10, 2023
Est. full return
Aug 10, 2026
Reports on file
15
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
GRANISETRON HYDROCHLORIDE INJECTION
1MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02322765 · since May 1, 2026, est. end Aug 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP GRANISETRON
1MG · TABLET · JAMP PHARMA CORPORATION
DIN 02472686 · since Jan 10, 2023, no end estimate · Disruption of the manufacture of the drug.
Resolved
GRANISETRON HYDROCHLORIDE INJECTION
1MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02322765 · ended Feb 17, 2026 · Disruption of the manufacture of the drug.
Resolved
GRANISETRON HYDROCHLORIDE INJECTION
1MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02322765 · ended Oct 22, 2025 · Disruption of the manufacture of the drug.
Resolved
GRANISETRON HYDROCHLORIDE INJECTION
1MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02322765 · ended Jul 14, 2025 · Disruption of the manufacture of the drug.
Resolved
GRANISETRON HYDROCHLORIDE INJECTION
1MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02322765 · ended Mar 8, 2024 · Demand increase for the drug.
Resolved
GRANISETRON HYDROCHLORIDE INJECTION
1MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02322765 · ended Jan 18, 2024 · Demand increase for the drug.
Resolved
GRANISETRON HYDROCHLORIDE INJECTION
1MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02322765 · ended Oct 18, 2023 · Demand increase for the drug.
Resolved
GRANISETRON HYDROCHLORIDE INJECTION
1MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02322765 · ended Aug 1, 2023 · Demand increase for the drug.
Resolved
GRANISETRON HYDROCHLORIDE INJECTION
1MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02322765 · ended Jun 13, 2023 · Demand increase for the drug.
Resolved
GRANISETRON HYDROCHLORIDE INJECTION
1MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02322765 · ended Feb 23, 2023 · Demand increase for the drug.
Resolved
GRANISETRON HYDROCHLORIDE INJECTION
1MG · LIQUID · OMEGA LABORATORIES LTD
DIN 02322765 · ended Jul 30, 2021 · Disruption of the manufacture of the drug.
Showing 12 of 15 reports. All reports are on file with Health Canada.
What's happening
Granisetron is currently affected by 2 active shortage reports filed with Health Canada by OMEGA LABORATORIES LIMITED, JAMP PHARMA CORPORATION.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Granisetron is classified under “ANTIEMETICS AND ANTINAUSEANTS” (ATC A04AA).
Recent changes
Jul 29, 2026
Estimated end date pushed back : Aug 3, 2026 → Aug 10, 2026
Jul 22, 2026
Estimated end date pushed back : Jul 24, 2026 → Aug 3, 2026
Common questions
What is Granisetron used for?
An anti-nausea medication used to prevent nausea and vomiting caused by chemotherapy or surgery.
When will Granisetron be back in stock in Canada?
The latest manufacturer estimate is Aug 10, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Granisetron in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.